Pyramid Feature Iterative Fusion: A Cross-Scale Fusion Algorithm for Enhanced Analysis of H&E Images in HER2-Positive Breast Cancer

被引:0
|
作者
Xiong, Xiaomin [1 ]
Zhang, Yuqi [2 ]
Gu, Lihua [3 ]
Li, Yi [1 ]
Lin, Bo [4 ]
Lei, Dajiang [2 ]
Wang, Guoyin [2 ]
Xu, Bo [4 ]
机构
[1] Chongqing Univ, Sch Med, Chongqing, Peoples R China
[2] Chongqing Univ Posts & Telecommun, Chongqing, Peoples R China
[3] Chongqing Univ Posts & Telecommun, Chongqing City Management Coll, Chongqing, Peoples R China
[4] Chongqing Univ, Chongqing Key Lab Intelligent Oncol Breast Canc, Canc Hosp, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
HER2-positive breast cancer; Hematoxylin and Eosin (H&E) images; Convolutional Neural Network; Cross-scale Interpretability;
D O I
10.1109/ICDMW60847.2023.00045
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
For HER2-positive breast cancer patients, the presence of distant metastasis is a crucial prognostic element. Early detection can notably assist in devising treatment strategies, thereby improving patient prognosis. Pathological Hematoxylin and Eosin (H&E) whole-slide images (WSIs) provide a rich array of prognosis-related histological features. By conducting an exhaustive multi-scale analysis, a hierarchical model embodying core tumor trait can be established. Currently, prevalent techniques in multi-scale H&E image analysis entail concatenating feature vectors and applying attention mechanisms to calculate feature correlations. Nonetheless, due to insufficient cross-scale correlation constraints, these methods might generate redundant information. This paper introduces Pyramid Feature Iterative Fusion (PFIF), a groundbreaking cross-scale fusion algorithm for H&E images. PFIF resolves the issues of redundancy and reduces noise following fusion. By integrating a backward feature fusion module, it emulates human evaluation of H&E images across scales. It amalgamates structural semantic features from a low-magnification view with texture features from a highmagnification view, thereby conveying key complementary details across resolutions. Training this model with H&E image data from Chongqing University's Cancer Hospital resulted in an AUC rate improvement of approximately 3.69.
引用
收藏
页码:311 / 317
页数:7
相关论文
共 36 条
  • [1] CF2PN: A Cross-Scale Feature Fusion Pyramid Network Based Remote Sensing Target Detection
    Huang, Wei
    Li, Guanyi
    Chen, Qiqiang
    Ju, Ming
    Qu, Jiantao
    REMOTE SENSING, 2021, 13 (05) : 1 - 23
  • [2] Computer vision detects morphological correlates of HER2 positive breast cancer in H&E stained histological images
    Dhage, S.
    Anand, D.
    Kumar, N.
    Gann, P. H.
    Sethi, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [3] A Hybrid Feature Fusion Network for Predicting HER2 Status on H&E-Stained Histopathology Images
    Zhang, Pei
    Liu, Zhihong
    Liu, Liangliang
    BIOINFORMATICS RESEARCH AND APPLICATIONS, PT II, ISBRA 2024, 2024, 14955 : 38 - 46
  • [4] Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer
    Ahmadzadeh, Maryam
    Mohit, Elham
    BIOTECHNOLOGY LETTERS, 2023, 45 (03) : 371 - 385
  • [5] Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer
    Maryam Ahmadzadeh
    Elham Mohit
    Biotechnology Letters, 2023, 45 : 371 - 385
  • [6] In silico and experimental methods for designing a potent anticancer arazyme-herceptin fusion protein in HER2-positive breast cancer
    Rahmani, Farideh
    Imani Fooladi, Abbas Ali
    Ajoudanifar, Hatef
    Soleimani, Nazila Arbab
    JOURNAL OF MOLECULAR MODELING, 2023, 29 (05)
  • [7] In silico and experimental methods for designing a potent anticancer arazyme-herceptin fusion protein in HER2-positive breast cancer
    Farideh Rahmani
    Abbas Ali Imani Fooladi
    Hatef Ajoudanifar
    Nazila Arbab Soleimani
    Journal of Molecular Modeling, 2023, 29
  • [8] Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein
    Rahmani, Farideh
    Ajoudanifar, Hatef
    Soleimani, Nazila Arbab
    Fooladi, Abbas Ali Imani
    BREAST CANCER, 2024, 31 (06) : 1101 - 1113
  • [9] Artificial Intelligence-Based Assessment of HER2-Low Expression on Breast Cancer H&E Digital Whole Slide Images
    Retamero, J.
    Oakley, J.
    Reis-Filho, J.
    Horton, M.
    Klimstra, D.
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S15 - S15
  • [10] Deep learning-based assessment of HER2-low expression on breast cancer H&E digital whole slide images
    Oakley, Gerard, III
    Reis-Filho, Jorge
    Klimstra, David
    Goldfinger, Marc
    Wang, Yikan
    Marra, Antonio
    CANCER RESEARCH, 2023, 83 (05)